News

Lo and behold, that same E. coli antibiotic, halicin, is also good at fighting other bacteria, in particular A. baumannii, the presence of which it drastically reduced in mice who'd been infected ...
New antibiotic halicin (top row) shows much stronger antibacterial effects against E. coli than existing antibiotic ciprofloxacin (bottom row), to which many bugs are already resistant.
The new compound is named Halicin, after the murderous AI from the movie "2001: A Space Odyssey." It has raised hopes that artificial intelligence might boost the lagging antibiotic development field.
AI identified Halicin to combat antibiotic-resistant bacteria efficiently Halicin disrupts bacterial membranes, blocking their reproduction This discovery showcases AI's role in revolutionizing ...
The algorithm that discovered halicin was trained on the molecular features of 2,500 compounds. Nearly half were FDA-approved drugs, and another 800 naturally occurring. The researchers specifically ...
Artificial intelligence is already showing promising results in finding new antibiotics.In 2019, researchers used a deep learning approach to identify the wide-spectrum antibiotic Halicin.
Researchers have used a new form of AI to discover a class of antibiotics that can kill methicillin-resistant Staphylococcus aureus, or MRSA.
The discovery of halicin paints a picture of just how rapid AI-assisted drug discovery can be. Scientists trained their AI model by introducing it to approximately 2,500 molecules (1,700 of which ...
Please use one of the following formats to cite this article in your essay, paper or report: APA. Bose, Priyom. (2023, December 20). Deep learning unlocks new antibiotic classes, revolutionizing ...
A researcher hoping to use AI will need to acquire not only a deep understanding of a particular problem—such as antibiotic resistance—but also the knowledge of which data, and what ...
Other AI approaches have also shown promise. An MIT group, in particular, has been focused on developing entirely new antibiotics to fight superbugs. Their first study, published in 2020, established ...
An antibiotic candidate that Collins' lab discovered in 2020, halicin, appears to work by a similar mechanism but is specific to Gram-negative bacteria (bacteria with thin cell walls).